LBX Pharmacy Chain JSC (SHSE:603883) EPS without NRI: ¥0.78 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603883 LBX Pharmacy Chain JSC SHSE:603883
81 GF Score
Price ¥12.73
GF Value ¥19.28
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is LBX Pharmacy Chain JSC EPS without NRI?

LBX Pharmacy Chain JSC SHSE:603883 +1.43% 81 EPS without NRI is ¥0.78 as of Mar. 2026. GuruFocus rates SHSE:603883 with a GF Score™ of 81/100 and a GF Value™ of ¥19.28 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 508 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks worse than 85.83% on this metric.

LBX Pharmacy Chain JSC's earnings per share without non-recurring items for the three months ended in Mar. 2026 was ¥0.35. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.78.

During the past 12 months, LBX Pharmacy Chain JSC's average earnings per share (NRI) Growth Rate was 9.70% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -22.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -9.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for LBX Pharmacy Chain JSC's EPS without NRI or its related term are showing as below:

SHSE:603883' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -22.2   Med: 11.95   Max: 23.8
Current: -22.2

During the past 13 years, LBX Pharmacy Chain JSC's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 23.80% per year. The lowest was -22.20% per year. And the median was 11.95% per year.

SHSE:603883's 3-Year EPS without NRI Growth Rate is ranked worse than
85.83% of 508 companies
in the Healthcare Providers & Services industry
Industry Median: 11.3 vs SHSE:603883: -22.20

LBX Pharmacy Chain JSC's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.52.

LBX Pharmacy Chain JSC's EPS (Basic) for the three months ended in Mar. 2026 was ¥0.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.52.


LBX Pharmacy Chain JSC  (SHSE:603883) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


LBX Pharmacy Chain JSC EPS without NRI Related Terms


LBX Pharmacy Chain JSC EPS without NRI Historical Data

* Premium members only.

The historical data trend for LBX Pharmacy Chain JSC's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LBX Pharmacy Chain JSC EPS without NRI Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.98 1.12 0.65 0.46

LBX Pharmacy Chain JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.19 0.18 0.06 0.35

LBX Pharmacy Chain JSC EPS without NRI Competitor Comparison

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's PE Ratio without NRI falls into.


SHSE:603883
81GF Score
LBX Pharmacy Chain JSC SHSE:603883
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LBX Pharmacy Chain JSC EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ¥0.78 mean?
LBX Pharmacy Chain JSC (SHSE:603883) has a EPS without NRI of ¥0.78 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LBX Pharmacy Chain JSC and its competitors. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #436 out of 508 companies in the Healthcare Providers & Services industry, placing it in the top 85.8%.
Is LBX Pharmacy Chain JSC's EPS without NRI too high?
LBX Pharmacy Chain JSC's current EPS without NRI is ¥0.78. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #436 out of 508 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #436 out of 508 companies for EPS without NRI. This places LBX Pharmacy Chain JSC in the lower half of its industry. The industry median EPS without NRI is 11.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.30, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current EPS without NRI is ¥0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.28, compared to a current price of ¥12.73 — trading 34% below its estimated fair value. The current EPS without NRI is ¥0.78. LBX Pharmacy Chain JSC's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current EPS without NRI is ¥0.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?

Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued. The current stock price of ¥12.73 is trading 34% below its estimated GF Value™ of ¥19.28. GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.

Key valuation signals for SHSE:603883:

  • EPS without NRI: ¥0.78
  • GF Value™: ¥19.28 vs. price of ¥12.73 (34% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LBX Pharmacy Chain JSC Business Description

Address No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
81GF Score

Get the complete analysis for SHSE:603883

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.73
Price
¥19.28
GF Value